Warning: The NCBI web site requires JavaScript to function. more...
Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis.
Nevin RL.
Malar J. 2009 Aug 5;8:188.
Related citations
Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.
Nevin RL, Pietrusiak PP, Caci JB.
Malar J. 2008 Feb 11;7:30.
The position of mefloquine as a 21st century malaria chemoprophylaxis.
Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG.
Malar J. 2010 Dec 9;9:357. Review.
Mefloquine-induced grand mal seizure during malaria chemoprophylaxis in a non-epileptic subject.
Pous E, Gascón J, Obach J, Corachan M.
Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):434. No abstract available.
Controversies and misconceptions in malaria chemoprophylaxis for travelers.
Chen LH, Wilson ME, Schlagenhauf P.
JAMA. 2007 May 23;297(20):2251-63. Review.
Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
Matsumura T, Fujii T, Miura T, Koibuchi T, Endo T, Nakamura H, Odawara T, Iwamoto A, Nakamura T.
J Infect Chemother. 2005 Aug;11(4):196-8.
Mefloquine-induced grand mal seizure in tubercular meningitis.
Bregani ER, Tien TV, Figini G.
Panminerva Med. 1998 Dec;40(4):345-6.
[Convulsions and shock during antimalarial chemoprophylaxis with mefloquine].
Meyer P, Combes N, Corne P, Jonquet O.
Presse Med. 2003 Mar 8;32(9):408. French. No abstract available.
[Convulsions during prophylactic use of mefloquine].
Heeringa M, Kuster JA, Meyboom RH, Bouvy M.
Ned Tijdschr Geneeskd. 1998 Nov 7;142(45):2477-80. Dutch.
Paranoid psychosis related to mefloquine antimalarial prophylaxis.
Fuller SJ, Naraqi S, Gilessi G.
P N G Med J. 2002 Sep-Dec;45(3-4):219-21.
Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
Croft AM, Herxheimer A.
BMC Public Health. 2002 Mar 25;2:6.
Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions.
Bem JL, Kerr L, Stuerchler D.
J Trop Med Hyg. 1992 Jun;95(3):167-79.
[Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases].
Lebain P, Juliard C, Davy JP, Dollfus S.
Encephale. 2000 Jul-Aug;26(4):67-70. French.
Mefloquine-induced pneumonitis.
Soentjens P, Delanote M, Van Gompel A.
J Travel Med. 2006 May-Jun;13(3):172-4.
Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers.
Korhonen C, Peterson K, Bruder C, Jung P.
Am J Prev Med. 2007 Sep;33(3):194-9.
Experiences with malaria chemoprophylaxis in Dutch troops.
Buma AH, van Thiel P.
Med Trop (Mars). 2001;61(1):77-8. Review.
Multifocal myoclonus associated with mefloquine chemoprophylaxis.
Jiménez-Huete A, Gil-Nagel A, Franch O.
Clin Neuropharmacol. 2002 Sep-Oct;25(5):243. No abstract available.
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.
Alisky JM, Chertkova EL, Iczkowski KA.
Med Hypotheses. 2006;67(5):1090-4. Epub 2006 Jul 14.
Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.
Tran TM, Browning J, Dell ML.
Malar J. 2006 Aug 23;5:74.
Reversible hearing loss in temporal association with chemoprophylactic mefloquine use.
Wise M, Toovey S.
Travel Med Infect Dis. 2007 Nov;5(6):385-8. Epub 2007 Oct 26.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on